Evidence map›Paper›PMID 19103434›Full record

Trial reportBiological psychiatry2009

The role of cystine-glutamate exchange in nicotine dependence in rats and humans.

Lori A Knackstedt, Steven LaRowe, Pascale Mardikian, Robert Malcolm, Himanshu Upadhyaya, Sarra Hedden, Athina Markou, Peter W Kalivas

2 registry-linked trialsOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Biological psychiatry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 173 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
173citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03220776 phase2completednot on this mapstarted 2017, after this paper: background citation

Imaging Framework for Testing GABAergic/Glutamatergic Drugs in Bipolar Alcoholics

TypeinterventionalSponsorMedical University of South CarolinaRan2017 to 2022Enrolled54ConditionsAlcohol Use Disorder, Bipolar DisorderArmsN-Acetylcysteine, Gabapentin, Placebo Oral Tablet
NCT05903014 phase4completednot on this mapstarted 2023, after this paper: background citation

Effectiveness of N-Acetylcysteine in Motivational Enhancement Therapy for Nicotine Addiction: Study on the Dopaminergic Pathways, Changes in Functional Connectivity of fMRI Bold, and Changes in Smoking Abstinence

TypeinterventionalSponsorIndonesia UniversityRan2023 to 2023Enrolled90ConditionsNicotine Dependence, Nicotine AddictionArmsn-acetylcysteine, Motivational Enhancement Therapy
3 · Its place in the literature

Who cites it

173 citing papers in PubMed, 1 synthesis or guideline pooled it, 259 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Short-term nicotine deprivation alters dorsal anterior cingulate glutamate concentration and concomitant cingulate-cortical functional connectivity.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Trial
  6. Trial
  7. Trial
  8. Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-Induced Smoking Cessation.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2016
    Trial
  9. Trial
  10. N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study.Redox report : communications in free radical research · 2015
    Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2012
    Trial
  17. Trial
  18. Trial
  19. Trial
  20. The neuroimmune-glutamate hypothesis of addiction.Neuroscience and biobehavioral reviews · 2026
    Review

113 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lori A KnackstedtDepartment of Neurosciences, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Steven LaRowe
Pascale Mardikian
Robert Malcolm
Himanshu Upadhyaya
Sarra Hedden
Athina Markou
Peter W Kalivas
Medical University of South Carolina · USUniversity of California, San Diego · US

Funding

Selective Restoration of KCNQ Channel Inhibition in the PFC to Inhibit Cue-InducP50DA015369 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KALIVAS, PETER W · 2003 to 2017
$18.6M
GLUTAMATE AND CRAVING FOR COCAINER01DA012513 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KALIVAS, PETER W · 2000 to 2024
$7.5M
OPIOIDS, AMPHETAMINE &COCAIN IN DRUG ABUSER01DA003906 · NIDA · WASHINGTON STATE UNIVERSITY · PI KALIVAS, PETER W · 1985 to 2019
$3.6M
COCAINE, OPIOIDS AND DRUG ABUSER37DA003906 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KALIVAS, PETER W · 2000 to 2009
$3.0M
NEUROBIOLOGY OF NICOTINE REWARD AND WITHDRAWALR01DA011946 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MARKOU, ATHINA · 2000 to 2011
$2.4M
Neurobiology of Nicotine Reward and WithdrawalR56DA011946 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MARKOU, ATHINA · 2013 to 2014
$659k
Striatal Glutamate Homeostasis and Cocaine RelapseR21DA026010 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KNACKSTEDT, LORI A · 2008 to 2009
$406k
NIDA NIH HHS P50 DA015369NIDA NIH HHS P50DA015369NIDA NIH HHS R01 DA003906NIDA NIH HHS R01 DA011946NIDA NIH HHS R01 DA012513NIDA NIH HHS R01DA03906NIDA NIH HHS R01DA1194NIDA NIH HHS R21 DA026010NIDA NIH HHS R37 DA003906NIDA NIH HHS R56 DA011946
6 · The paper itself

Abstract

backgroundThe present study determined if, akin to cocaine, nicotine self-administration in rats induces adaptations in the expression of glutamate transporters and cystine-glutamate exchangers in brain nuclei implicated in reinforcement and if treating cigarette smokers with a drug that restores cystine-glutamate exchange affects the number of cigarettes smoked.

methodsRats self-administered nicotine intravenously for 12 hours/day or received nicotine through osmotic minipumps for 21 days. Somatic signs of withdrawal were measured and immunoblotting was performed 12 hours after the last nicotine exposure to determine if the catalytic subunit of the cystine-glutamate exchanger, xCT, or the glial glutamate transporter, GLT-1, were altered in the ventral tegmental area (VTA), nucleus accumbens, prefrontal cortex, or amygdala. For the smoking reduction study in humans, nicotine-dependent smokers were treated for 4 weeks with N-acetylcysteine (2400 mg daily) to promote cystine-glutamate exchange or placebo. Participants provided weekly ratings of withdrawal symptoms, craving, and carbon monoxide (CO) measurements and logged daily cigarette and alcohol use.

resultsRats receiving nicotine via self-administration or minipumps displayed somatic signs of withdrawal, but only nicotine self-administering rats showed decreased xCT expression in the nucleus accumbens and VTA and decreased GLT-1 expression in the nucleus accumbens. Human smokers treated with N-acetylcysteine reported a reduction in cigarettes smoked, and there was no effect of N-acetylcysteine on estimates of CO levels, craving, or withdrawal.

conclusionsThese results indicate that the cystine-glutamate exchanger and the glial glutamate transporter are downregulated after nicotine self-administration, and augmenting exchanger activity with N-acetylcysteine reduced the number of cigarettes smoked in nicotine-dependent individuals.

Indexed as

AcetylcysteineAmino Acid Transport System y+AmygdalaAnimalsBrainCarbon MonoxideExcitatory Amino Acid Transporter 2FemaleHumansMaleMiddle AgedNicotineNucleus AccumbensPilot ProjectsPrefrontal CortexRatsAcetylcysteineAmino Acid Transport System y+Carbon MonoxideExcitatory Amino Acid Transporter 2NicotineSLC7A11 protein, human

Identifiers

PMID19103434
PMCPMC2756612
OpenAlexW2088991430

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.